In this video, Shahzad Raza, MD, discusses safety and efficacy data from Nexicart-2, which studied the use of chimeric antigen receptor T-cell therapy in relapsed or refractory light chain amyloidosis ...

In this video, Shahzad Raza, MD, discusses teclistamab as a potential treatment for patients with relapsed or refractory systemic light chain amyloidosis.“Teclistamab has already been approved in ...

Cardiac amyloidosis is a manifestation of one of several systemic diseases known as the amyloidoses. 1,2 This uncommon disease is probably underdiagnosed, and even when a diagnosis of amyloidosis of ...